Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-21-009110

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 14, 2021 78.7M sh
Cash And Equivalents Q2 2021 · Jun 30, 2021 $27.76K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $55.43K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $83.41K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $130.35K
Total Liabilities Q2 2021 · Jun 30, 2021 $2.54M
Total Liabilities Q2 2021 · Dec 31, 2020 $2.44M
Current Assets Q2 2021 · Jun 30, 2021 $27.76K
Current Assets Q2 2021 · Dec 31, 2020 $55.43K
Total Assets Q2 2021 · Jun 30, 2021 $27.76K
Total Assets Q2 2021 · Dec 31, 2020 $55.43K
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$46.94K
Stockholders Equity Q2 2021 · Jun 30, 2020 −$2.25M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$2.17M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$2.13M
Sga Expense Q2 2021 · Jun 30, 2020 $2.99K
Sga Expense Q2 2021 · Jun 30, 2020 $6.89K
Net Income Q2 2021 · Jun 30, 2020 −$79.33K
Net Income Q2 2021 · Jun 30, 2020 −$124K
Operating Income Q2 2021 · Jun 30, 2020 −$25.44K
Operating Income Q2 2021 · Jun 30, 2020 −$40.84K